Last reviewed · How we verify
NCT02871596
Effect of a Proprietary Dietary Supplement on Fecal Volatile Organic Compounds - a Randomized, Placebo-controlled, Double-blind, Cross-over Study
NA trial testing Placebo in Healthy in 27 participants. Completed in 1 February 2017.
1 February 2017
Quick facts
| Lead sponsor | Pharmanex |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | quadruple |
| Primary purpose | other |
| Enrollment | 27 |
| Start date | 1 August 2016 |
| Primary completion | 1 February 2017 |
| Estimated completion | 1 February 2017 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Placebo
- Flavonoids — full drug profile →
- Flavonoids+Prebiotics
Conditions studied
- Healthy — all drugs for Healthy →
Sponsor
Pharmanex
Who can join
Adults 18 to 70, any sex, with Healthy. Healthy volunteers can join.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
-
Change from baseline in fecal volatile methyl sulfides at day 21, day 63, day 105
Time frame: baseline, day 21, day 63, day 105
assessed by gas chromatograph - mass spectrometry (GC-MS) headspace analysis
Sponsor's own description
The purpose of the study is to determine the effects of both an anthocyanin-rich polyphenol blend and an anthocyanin-rich polyphenol blend combined with a prebiotic blend on fecal microbiota metabolism (assessed by gas chromatograph - mass spectrometry (GC-MS) headspace analysis) and fecal microbiota composition (assessed by next generation sequencing).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT02871596
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Flavonoids
Trials testing the same drug.
- NCT06064838 — Effects of Cacao Flavonoids in Long COVID-19 Patients (FLALOC) · NA · completed
- NCT02782455 — Calcium Dobesilate vs Flavonoids for the Treatment of Early Hemorrhoidal Disease · Phase 4 · completed
Other recruiting trials for Healthy
Currently open trials in the same condition.
- NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
- NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
- NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
- NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
- NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting
Other Pharmanex trials
Trials by the same sponsor.
- NCT07380438 — A Clinical Study to Evaluate the Efficacy of a Nutritional Supplement to Improve Carotenoid Content as Measured by a Non · NA · completed
- NCT06680219 — Evaluation of the the Efficacy of a Digestive Health Supplement in Healthy Subjects · NA · completed
- NCT05971771 — Study to Assess Impact of Dietary Supplement on Sleep Health · NA · unknown
- NCT06672965 — A Clinical Study to Evaluate the Efficacy of Dietary Supplement to Alleviate Stress Versus Placebo in Subjects with Mild · NA · completed
- NCT05041205 — Functional Test for a Drink Powder Alone and Combined Use With a Cosmetic Apparatus · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02871596 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Pharmanex
- Last refreshed: 21 February 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02871596.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing